A detailed history of Fin Trust Capital Advisors, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Fin Trust Capital Advisors, LLC holds 3,424 shares of BSX stock, worth $309,735. This represents 0.05% of its overall portfolio holdings.

Number of Shares
3,424
Previous 4,424 22.6%
Holding current value
$309,735
Previous $340,000 15.88%
% of portfolio
0.05%
Previous 0.06%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 11, 2024

SELL
$72.96 - $84.0 $72,960 - $84,000
-1,000 Reduced 22.6%
3,424 $286,000
Q2 2024

Jul 24, 2024

BUY
$67.33 - $77.71 $4,780 - $5,517
71 Added 1.63%
4,424 $340,000
Q1 2024

May 02, 2024

SELL
$57.6 - $68.62 $48,096 - $57,297
-835 Reduced 16.09%
4,353 $298,000
Q3 2023

Oct 24, 2023

SELL
$50.19 - $54.68 $1.73 Million - $1.88 Million
-34,468 Reduced 86.92%
5,188 $273,000
Q4 2022

Feb 14, 2023

SELL
$39.56 - $47.22 $133,594 - $159,461
-3,377 Reduced 7.85%
39,656 $1.84 Million
Q3 2022

Oct 20, 2022

BUY
$36.71 - $109.66 $21,438 - $64,041
584 Added 1.38%
43,033 $1.77 Million
Q2 2022

Jul 26, 2022

SELL
$35.24 - $47.1 $30,905 - $41,306
-877 Reduced 2.02%
42,449 $1.62 Million
Q1 2022

May 03, 2022

BUY
$40.9 - $45.1 $328,508 - $362,243
8,032 Added 22.76%
43,326 $1.92 Million
Q4 2021

Feb 14, 2022

SELL
$38.07 - $44.87 $33,311 - $39,261
-875 Reduced 2.42%
35,294 $1.5 Million
Q3 2021

Nov 16, 2021

BUY
$41.23 - $45.88 $90,417 - $100,614
2,193 Added 6.45%
36,169 $1.57 Million
Q2 2021

Aug 16, 2021

BUY
$38.58 - $44.24 $1.31 Million - $1.5 Million
33,976 New
33,976 $1.45 Million
Q4 2020

Feb 16, 2021

SELL
$33.15 - $41.97 $5,204 - $6,589
-157 Closed
0 $0
Q2 2020

Sep 11, 2020

BUY
$30.19 - $39.11 $4,739 - $6,140
157 New
157 $6,000
Q2 2020

Aug 14, 2020

SELL
$30.19 - $39.11 $7,758 - $10,051
-257 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$25.83 - $45.71 $2,583 - $4,571
-100 Reduced 28.01%
257 $8,000
Q4 2019

Jan 23, 2020

BUY
$37.87 - $45.37 $4,506 - $5,399
119 Added 50.0%
357 $16,000
Q3 2019

Oct 29, 2019

SELL
$40.31 - $43.45 $5,079 - $5,474
-126 Reduced 34.62%
238 $10,000
Q2 2019

Aug 01, 2019

SELL
$34.91 - $42.98 $14,452 - $17,793
-414 Reduced 53.21%
364 $16,000
Q1 2019

May 09, 2019

SELL
$32.91 - $40.75 $82,274 - $101,875
-2,500 Reduced 76.27%
778 $30,000
Q4 2018

Feb 11, 2019

BUY
$31.73 - $39.04 $104,010 - $127,973
3,278 New
3,278 $115,000

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $130B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Fin Trust Capital Advisors, LLC Portfolio

Follow Fin Trust Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fin Trust Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fin Trust Capital Advisors, LLC with notifications on news.